Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy [Phase 3]
Phase 3 study evaluating the efficacy, safety and tolerability of TMC435 (simeprevir) in genotype 1 hepatitis C patients who relapsed after …
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: A Study to Assess the Effectiveness, Safety, and Pharmacokinetics of TMC435 in Combination With Peginterferon Alfa-2a and Ribavirin in Hepatitis-C Infected Patients [Phase 2]
This Phase 2 trial assessed the effectiveness, safety, and pharmacokinetics of TMC435 with peginterferon alfa-2a and ribavirin in chronic he…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Hepatitis C in Renal Transplant Recipients [Phase 4]
Phase 4 clinical trial update addressing chronic hepatitis C infection in renal transplant recipients; the snippet provides no status or res…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C Infection [Phase 1]
Phase 1 trial update showing safety, tolerability, and pharmacokinetics of escalating doses of VCH 916 in subjects with hepatitis C.
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs) [NA]
A completed clinical trial assessing the impact of motivational interviewing on risky injecting behaviors among injecting drug users, with p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Phase 3 Study of Sofosbuvir and Ribavirin [Phase 3]
A Phase 3 study evaluating the combination of Sofosbuvir and Ribavirin for Hepatitis C has completed. Results were posted in April 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Pharmacokinetics of Multiple Ascending Doses of VCH-222 in Subjects With Chronic Hepatitis C Infection [Phase 1, Phase 2]
A clinical trial update describing pharmacokinetics results from multiple ascending doses of VCH-222 in subjects with chronic hepatitis C (P…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study) [Phase 2]
A Phase 2 trial completed evaluating the safety of two medications for treating hepatitis C in people with thalassemia.
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Virology Follow up Study in Subjects Previously Treated With Telaprevir
A completed clinical trial update reporting virology follow-up results in hepatitis C patients previously treated with telaprevir.
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Ribavirin Dose Optimization for the Treatment of Hepatitis C [Phase 2]
A Phase 2 clinical trial update reporting ribavirin dose optimization for chronic hepatitis C; the study is completed.
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients [Phase 2]
Phase 2 dose-ranging trial evaluating sofosbuvir in combination with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepati…
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients [Phase 2]
Phase 2 trial evaluating sofosbuvir with pegylated interferon and ribavirin in treatment-naive hepatitis C patients has completed and result…
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon [Phase 3]
Phase 3 trial evaluating 12 weeks of sofosbuvir plus ribavirin in adults with chronic hepatitis C genotype 2 or 3 who are interferon intoler…
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir [Phase 1]
Phase 1 trial update evaluating multiple doses of TMC647055 in combination with telaprevir for Hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients [Phase 1]
A Phase 1 study of PF-00868554 in hepatitis C virus–positive patients has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Virological Response Study of the HCV Vaccine IC41 [Phase 2]
Phase 2 study evaluating the HCV vaccine IC41 in chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection [Phase 2]
This Phase 2 trial evaluated oral antiviral regimens that include GS-5885 (ledipasvir), Tegobuvir, and/or GS-9451, in combination with pegin…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: A Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard Treatment [Phase 2]
A Phase 2 safety and effectiveness study of TMC435 in chronic genotype 1 hepatitis C patients who failed prior standard treatment has comple…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: A Study of TMC435350 Administered With or Without Standard of Care Therapy in Participants With Genotype 1 Hepatitis C Virus Infection [Phase 2]
Phase 2 study evaluating TMC435350 with or without standard of care in genotype 1 chronic hepatitis C; results from the trial have been post…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection [Phase 2]
A Phase 2 safety study evaluating regimens of Sofosbuvir, GS-0938, and Ribavirin in patients with chronic hepatitis C infection has complete…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C [Phase 2]
Phase 2 study evaluating response-guided duration of combination therapy with GS-9451, Pegasys (peginterferon alfa-2a) and Copegus (ribaviri…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: A Study of TMC435 in Genotype 1, Hepatitis C-infected Patients Who Relapsed After Previous Interferon (IFN)-Based Therapy [Phase 3]
A Phase 3 trial evaluating TMC435 in genotype 1 hepatitis C patients who relapsed after interferon-based therapy has completed, with results…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus Infection [Phase 2]
Phase 2 study of GS-9450 for chronic hepatitis C virus infection has been terminated; the update notes status but does not provide efficacy …
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus [Phase 2]
Phase 2 clinical trial update evaluating GS-5885 (ledipasvir) alone or with GS-9451 in combination with peginterferon alfa-2a and ribavirin …
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype [Phase 2]
Phase 2 study of GS-5885 (ledipasvir) and GS-9451 in combination with peginterferon alfa-2a and ribavirin for treatment-naïve chronic genoty…